J&J to discontinue HIV vaccine trial

Published by
Reuters

By Leroy Leo

(Reuters) -Johnson & Johnson said on Wednesday that it was pulling the plug on a late-stage global trial of an HIV vaccine after the shot was found ineffective at preventing infections.

The trial’s failure marks yet another setback in the search for a vaccine against a virus known to mutate rapidly and find unique ways to evade the immune system, and comes more than a year after another of J&J’s HIV vaccine failed a study.

“It’s not the outcome we had hoped for, unfortunately,” said a spokesperson for the National Institute of Allergy and Infectious Diseases (NIAID), a J&J partner in the trial.

“The development of a safe and effective HIV vaccine has been a considerable scientific

READ MORE OF THIS POST AT TowleRoad